GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2577.5 and 2629.8
| Intraday Target 1 | 2536.17 |
| Intraday Target 2 | 2566.53 |
| Intraday Target 3 | 2588.4666666667 |
| Intraday Target 4 | 2618.83 |
| Intraday Target 5 | 2640.77 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 20 February 2026 | 2596.90 (0.74%) | 2577.00 | 2558.10 - 2610.40 | 0.4143 times | Thu 19 February 2026 | 2577.90 (-0.23%) | 2584.00 | 2560.00 - 2625.00 | 0.6047 times | Wed 18 February 2026 | 2583.80 (-0.76%) | 2603.60 | 2578.60 - 2644.00 | 0.4741 times | Tue 17 February 2026 | 2603.60 (0.24%) | 2590.80 | 2579.00 - 2627.00 | 0.9298 times | Mon 16 February 2026 | 2597.30 (0.11%) | 2590.00 | 2584.80 - 2639.00 | 0.3609 times | Fri 13 February 2026 | 2594.40 (-2.78%) | 2645.00 | 2584.80 - 2668.50 | 0.647 times | Thu 12 February 2026 | 2668.50 (-1.14%) | 2705.70 | 2644.80 - 2705.70 | 0.4604 times | Wed 11 February 2026 | 2699.30 (2.91%) | 2622.00 | 2610.00 - 2719.80 | 1.2185 times | Tue 10 February 2026 | 2622.90 (4.24%) | 2550.40 | 2541.60 - 2675.00 | 3.7787 times | Mon 09 February 2026 | 2516.20 (1.3%) | 2489.00 | 2475.00 - 2540.00 | 1.1116 times | Fri 06 February 2026 | 2484.00 (1.61%) | 2444.60 | 2405.00 - 2489.00 | 0.7971 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2577.5 and 2663.4
| Weekly Target 1 | 2513.77 |
| Weekly Target 2 | 2555.33 |
| Weekly Target 3 | 2599.6666666667 |
| Weekly Target 4 | 2641.23 |
| Weekly Target 5 | 2685.57 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 0.6829 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 1.7702 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 0.9052 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 0.8026 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.0387 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.5681 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9644 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 1.9525 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4638 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.8515 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.3326 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2469.5 and 2847.2
| Monthly Target 1 | 2175.23 |
| Monthly Target 2 | 2386.07 |
| Monthly Target 3 | 2552.9333333333 |
| Monthly Target 4 | 2763.77 |
| Monthly Target 5 | 2930.63 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 20 February 2026 | 2596.90 (8.13%) | 2421.40 | 2342.10 - 2719.80 | 0.5548 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.5867 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.9588 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.7997 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.5193 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.8272 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.1448 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.6989 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.3985 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.5113 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.8774 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2408.6 and 2908.1
| Yearly Target 1 | 2012.83 |
| Yearly Target 2 | 2304.87 |
| Yearly Target 3 | 2512.3333333333 |
| Yearly Target 4 | 2804.37 |
| Yearly Target 5 | 3011.83 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 20 February 2026 | 2596.90 (4.98%) | 2476.00 | 2220.30 - 2719.80 | 0.1505 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6725 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2721 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2631 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7336 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9786 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0921 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4671 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2376 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1329 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1331 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2566.29 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Munafa value: 75 as on Fri 20 February 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2510 and price is deviating by 106 points
Upper Bollinger band is at 2721 and lower is at 2299, while middle bands are at 2404 and 2616
Price is rising
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2612.23 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2591.9 |
| 12 day DMA | 2582.45 |
| 20 day DMA | 2509.53 |
| 35 day DMA | 2455.01 |
| 50 day DMA | 2474.87 |
| 100 day DMA | 2545.74 |
| 150 day DMA | 2648.17 |
| 200 day DMA | 2781.61 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2592.35 | 2590.07 | 2596.16 |
| 12 day EMA | 2566.3 | 2560.74 | 2557.62 |
| 20 day EMA | 2533.37 | 2526.69 | 2521.3 |
| 35 day EMA | 2514.59 | 2509.74 | 2505.73 |
| 50 day EMA | 2492.65 | 2488.4 | 2484.75 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2591.9 | 2591.4 | 2609.52 |
| 12 day SMA | 2582.45 | 2566.63 | 2554.75 |
| 20 day SMA | 2509.53 | 2495.36 | 2485.47 |
| 35 day SMA | 2455.01 | 2450.98 | 2448 |
| 50 day SMA | 2474.87 | 2474.8 | 2474.42 |
| 100 day SMA | 2545.74 | 2546.5 | 2548.1 |
| 150 day SMA | 2648.17 | 2651.98 | 2656.12 |
| 200 day SMA | 2781.61 | 2782.88 | 2784.2 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 46.05
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 46.3
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


